Omega-3 Fatty Acids (EPA/DHA)
Treatment for Dry Eye Disease
Effectiveness
60%
Safety Score
85%
Clinical Trials
9
Participants
12K
Comparative Safety Scale(Higher is safer)
Cyanideβ οΈ
Methπ
Cigarettesπ¬
Chemoβ’οΈ
AlcoholπΊ
Morphineπ
Antibioticsπ
Tylenolπ
Exerciseπ
Waterπ§
85
DangerousModerateSafe
Treatment Details
0
Omega-3 Fatty Acids (EPA/DHA) Outcomes
for Dry Eye Disease
Efficacy Outcomes
Overall Effectiveness
+60%
WARNING: LIMITED TRIALS AVAILABLE
You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!
Active Clinical Trials
No active trials currently recruiting for this treatment
No active trials found in ClinicalTrials.gov
Completed Clinical Trials
4 completed trials for Omega-3 Fatty Acids (EPA/DHA) in Dry Eye Disease
Dry Eye Assessment and Management: Feasibility Study
NCT01102257COMPLETEDPHASE2, PHASE3
23 participants
INTERVENTIONAL
New York, United States
Started: Jan 1, 2010
Dry Eye Assessment and Management Study
NCT02128763COMPLETEDPHASE3
535 participants
INTERVENTIONAL
Scottsdale, United States +26 more
Started: Nov 1, 2014
A Placebo Controlled Double Masked Clinical Assessment Study of Essential Fatty Acid Supplement and Its Effect on Patients With Apparent Aqueous Deficient Dry Eye Syndrome
NCT00344721COMPLETEDNA
42 participants
INTERVENTIONAL
Dallas, United States
Started: Sep 1, 2004
The Effects of Dietary Supplementation With Omega-3 Fatty Acids on Symptoms of Dry Eye
NCT03141931COMPLETEDNA
119 participants
INTERVENTIONAL
Sydney, Australia
Started: Aug 21, 2017